These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24247974)

  • 81. Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposure.
    Gökkaya M; Damialis A; Nussbaumer T; Beck I; Bounas-Pyrros N; Bezold S; Amisi MM; Kolek F; Todorova A; Chaker A; Aglas L; Ferreira F; Redegeld FA; Brunner JO; Neumann AU; Traidl-Hoffmann C; Gilles S
    J Allergy Clin Immunol; 2020 Sep; 146(3):583-594.e6. PubMed ID: 32272131
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Exposure to Cypress Pollens and Subsequent Symptoms: A Panel Study.
    Rakotozandry T; Cassagne E; Martin S; Alauzet P; Navarro I; Delcroux C; Caillaud D; Besancenot JP; Thibaudon M; Charpin D
    Int Arch Allergy Immunol; 2019; 180(2):135-141. PubMed ID: 31390631
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Specific probiotics alleviate allergic rhinitis during the birch pollen season.
    Ouwehand AC; Nermes M; Collado MC; Rautonen N; Salminen S; Isolauri E
    World J Gastroenterol; 2009 Jul; 15(26):3261-8. PubMed ID: 19598302
    [TBL] [Abstract][Full Text] [Related]  

  • 84.
    Mahmood F; Hetland G; Nentwich I; Mirlashari MR; Ghiasvand R; Nissen-Meyer LSH
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31581605
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure.
    Jacobs RL; Harper N; He W; Andrews CP; Rather CG; Ramirez DA; Ahuja SK
    J Allergy Clin Immunol; 2014 May; 133(5):1340-6, 1346.e1-7. PubMed ID: 24331377
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
    Möller C; Dreborg S; Ferdousi HA; Halken S; Høst A; Jacobsen L; Koivikko A; Koller DY; Niggemann B; Norberg LA; Urbanek R; Valovirta E; Wahn U
    J Allergy Clin Immunol; 2002 Feb; 109(2):251-6. PubMed ID: 11842293
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients.
    Yalcin AD; Basaran S; Bisgin A; Polat HH; Gorczynski RM
    Med Sci Monit; 2013 Feb; 19():102-10. PubMed ID: 23396359
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Ambient pollen exposure and pollen allergy symptom severity in the EPOCHAL study.
    Luyten A; Bürgler A; Glick S; Kwiatkowski M; Gehrig R; Beigi M; Hartmann K; Eeftens M
    Allergy; 2024 Jul; 79(7):1908-1920. PubMed ID: 38659216
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [A three year survey of the practical application of pollen monitoring in specific allergen immunotherapy].
    Myszkowska D; Stobiecki M; Dyga W; Majewska R; Czarnobilska E
    Przegl Lek; 2013; 70(12):1027-32. PubMed ID: 24720121
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cytokine production in peripheral blood cells during and outside the pollen season in birch-allergic patients and non-allergic controls.
    Wosinska-Becler K; Plewako H; Håkansson L; Rak S
    Clin Exp Allergy; 2004 Jan; 34(1):123-30. PubMed ID: 14720272
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Birch-pollen sensitization in an area without atmospheric birch pollens.
    Yamagiwa M; Hattori R; Ito Y; Yamamoto S; Kanba M; Tasaki T; Ueda K; Nishizumi T
    Auris Nasus Larynx; 2002 Jul; 29(3):261-6. PubMed ID: 12167448
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study.
    Blome C; Hadler M; Karagiannis E; Kisch J; Neht C; Kressel N; Augustin M
    Adv Ther; 2020 Jun; 37(6):2932-2945. PubMed ID: 32342352
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Birch pollen allergy].
    Lavaud F; Fore M; Fontaine JF; Pérotin JM; de Blay F
    Rev Mal Respir; 2014 Feb; 31(2):150-61. PubMed ID: 24602682
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Clinical symptoms of the allergic rhinitis and coexisting cross reactions in patients treated with the birch and/or grasses allergens against a background of the pollen exposure].
    Myszkowska D; Mazur M; Ziemianin M; Wach-Pizoń M; Czarnobilska E
    Przegl Lek; 2016; 73(12):791-6. PubMed ID: 29693973
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Seasonal allergic conjunctivitis in Hakodate].
    Takano Y; Narita S; Kobayashi K; Ito J; Kurose M; Chin S
    Nippon Ganka Gakkai Zasshi; 2004 Oct; 108(10):606-11. PubMed ID: 15559313
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of tear proteome in allergic rhinoconjunctivitis patients and controls with respect to pollen season.
    Tomazic PV; Liesinger L; Pucher B; Thallinger GG; Leitner A; Spoerk S; Gerstenberger C; Lang-Loidolt D; Birner-Gruenberger R
    Allergy; 2018 Jul; 73(7):1541-1543. PubMed ID: 29574764
    [No Abstract]   [Full Text] [Related]  

  • 97. Development and validation of a structured questionnaire for the diagnosis of oral allergy syndrome in subjects with seasonal allergic rhinitis during the UK birch pollen season.
    Skypala IJ; Calderon MA; Leeds AR; Emery P; Till SJ; Durham SR
    Clin Exp Allergy; 2011 Jul; 41(7):1001-11. PubMed ID: 21518043
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pollen-Food Allergy Syndrome: A not so Rare Disease in Childhood.
    Mastrorilli C; Cardinale F; Giannetti A; Caffarelli C
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31561411
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Health impact of exposure to pollens: A review of epidemiological studies].
    Caillaud D; Toloba Y; Raobison R; Besancenot JP; Thibaudon M; Martin S; Segala C
    Rev Mal Respir; 2014 Feb; 31(2):142-9. PubMed ID: 24602681
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Intranasal levels of lead as an exacerbation factor for allergic rhinitis in humans and mice.
    Xu H; Ohgami N; Sakashita M; Ogi K; Hashimoto K; Tazaki A; Tong K; Aoki M; Fujieda S; Kato M
    J Allergy Clin Immunol; 2021 Jul; 148(1):139-147.e10. PubMed ID: 33766551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.